z-logo
open-access-imgOpen Access
Dual roles of NF‐κB in cell survival and implications of NF‐κB inhibitors in neuroprotective therapy 1
Author(s) -
QIN Zhenghong,
TAO Luyang,
CHEN Xin
Publication year - 2007
Publication title -
acta pharmacologica sinica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.514
H-Index - 90
eISSN - 1745-7254
pISSN - 1671-4083
DOI - 10.1111/j.1745-7254.2007.00741.x
Subject(s) - neuroprotection , nf κb , programmed cell death , transcription factor , biology , microrna , nfkb1 , pathological , pathogenesis , neuroscience , cancer research , microbiology and biotechnology , immunology , medicine , signal transduction , apoptosis , gene , pathology , genetics
NF‐κB is a well‐characterized transcription factor with multiple physiological and pathological functions. NF‐κB plays important roles in the development and maturation of lymphoids, regulation of immune and inflammatory response, and cell death and survival. The influence of NF‐κB on cell survival could be protective or destructive, depending on types, developmental stages of cells, and pathological conditions. The complexity of NF‐κB in cell death and survival derives from its multiple roles in regulating the expression of a broad array of genes involved in promoting cell death and survival. The activation of NF‐κB has been found in many neurological disorders, but its actual roles in pathogenesis are still being debated. Many compounds with neuroprotective actions are strongly associated with the inhibition of NF‐κB, leading to speculation that blocking the pathological activation of NF‐κB could offer neuroprotective effects in certain neurodegenerative conditions. This paper reviews the recent developments in understanding the dual roles of NF‐κB in cell death and survival and explores its possible usefulness in treating neurological diseases. This paper will summarize the genes regulated by NF‐κB that are involved in cell death and survival to elucidate why NF‐κB promotes cell survival in some conditions while facilitating cell death in other conditions. This paper will also focus on the effects of various NF‐κB inhibitors on neuroprotection in certain pathological conditions to speculate if NF‐κB is a potential target for neuroprotective therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here